🇺🇸 Connaught in United States
131 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 131
Most-reported reactions
- Pyrexia — 31 reports (23.66%)
- Bovine Tuberculosis — 23 reports (17.56%)
- Haematuria — 15 reports (11.45%)
- Prostatitis — 12 reports (9.16%)
- Dysuria — 10 reports (7.63%)
- Interstitial Lung Disease — 10 reports (7.63%)
- Hypersensitivity — 8 reports (6.11%)
- Weight Decreased — 8 reports (6.11%)
- Asthenia — 7 reports (5.34%)
- Urinary Retention — 7 reports (5.34%)
Other Other approved in United States
Frequently asked questions
Is Connaught approved in United States?
Connaught does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Connaught in United States?
Swiss Cancer Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.